Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center Evaluation of Sleepiz One+ in Measuring Respiration Rate and Heart Rate Compared to Gold Standard

NCT05712226 is registered in ClinicalTrials.gov with Sleepiz AG as lead sponsor.

NCT NCT05712226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center Evaluation of Sleepiz One+ in Measuring Respiration Rate and Heart Rate Compared to Gold Standard
Lead sponsor
Sleepiz AG
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2023
Completion date
April 6, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, copd, heart diseases, hypertension, respiratory disease, sleep apnea